These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26714363)

  • 21. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsulation of Liquids Via Extrusion--A Review.
    Tackenberg MW; Kleinebudde P
    Curr Pharm Des; 2015; 21(40):5815-28. PubMed ID: 26446466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roll compaction/dry granulation: pharmaceutical applications.
    Kleinebudde P
    Eur J Pharm Biopharm; 2004 Sep; 58(2):317-26. PubMed ID: 15296958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encapsulation and controlled release of retinol from silicone particles for topical delivery.
    Shields CW; White JP; Osta EG; Patel J; Rajkumar S; Kirby N; Therrien JP; Zauscher S
    J Control Release; 2018 May; 278():37-48. PubMed ID: 29604311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
    Li C; Li C; Le Y; Chen JF
    Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excipient-drug interactions in parenteral formulations.
    Akers MJ
    J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under in-use Conditions with Different Administration Materials.
    Mueller C; Dietel E; Heynen SR; Nalenz H; Goldbach P; Mahler HC; Schmidt J; Grauschopf U; Schoenhamnmer K
    Int J Pharm Compd; 2015; 19(3):261-7. PubMed ID: 26714367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tableting of floating pellets with verapamil hydrochloride: influence of type of tablet press.
    Sawicki W; Łunio R
    Acta Pol Pharm; 2010; 67(1):103-6. PubMed ID: 20210087
    [No Abstract]   [Full Text] [Related]  

  • 30. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
    Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
    Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance.
    Rojas J; Buckner I; Kumar V
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1159-70. PubMed ID: 22966909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacing Synthetic Ingredients by Sustainable Natural Alternatives: A Case Study Using Topical O/W Emulsions.
    Bom S; Fitas M; Martins AM; Pinto P; Ribeiro HM; Marto J
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using a drug to structure its release matrix and release profile.
    Brook MA; Holloway AC; Ng KK; Hrynyk M; Moore C; Lall R
    Int J Pharm; 2008 Jun; 358(1-2):121-7. PubMed ID: 18407444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
    Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foam granulation: new developments in pharmaceutical solid oral dosage forms using twin screw extrusion machinery.
    Thompson MR; Weatherley S; Pukadyil RN; Sheskey PJ
    Drug Dev Ind Pharm; 2012 Jul; 38(7):771-84. PubMed ID: 22085462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting.
    Martinez M; Rathbone M; Burgess D; Huynh M
    J Control Release; 2008 Jul; 129(2):79-87. PubMed ID: 18514351
    [No Abstract]   [Full Text] [Related]  

  • 38. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.
    Sanganwar GP; Sathigari S; Babu RJ; Gupta RB
    Eur J Pharm Sci; 2010 Jan; 39(1-3):164-74. PubMed ID: 19961931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of excipients on transporter mediated absorption.
    Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
    Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation.
    Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z
    Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.